Quantbot Technologies LP Taysha Gene Therapies, Inc. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.39 - $2.98 $12,371 - $26,522	8,900 Added 1073.58%	9,729 $21,000
Q2 2022 Aug 09, 2022	SELL	$2.47 - $6.77 $5,187 - $14,217	-2,100 Reduced 71.7%	829 $3,000
Q1 2022 May 16, 2022	BUY	$5.22 - $11.86 $12,606 - $28,641	2,415 Added 469.84%	2,929 $19,000
Q4 2021 Feb 11, 2022	BUY	$11.43 - $19.2 $5,875 - $9,868	514 New	514 $5,000
Q4 2020 Feb 12, 2021	SELL	$19.14 - $28.13 $5,742 - $8,439	-300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$22.4 - $24.47 $6,720 - $7,341	300 New	300 $6,000

117

136M

25.9K

24K

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $85.1M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.